文献速递血栓与止血造血干细胞移植与细胞治疗

抗血小板因子4抗体与疫苗诱导免疫性血栓性血小板减少症患者脑静脉窦血栓形成风险

Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2023-06-30

该回顾性队列研究纳入2021年3月至6月确诊的疫苗诱导免疫性血栓性血小板减少症(VITT)患者39例,其中43.6%为PF4依赖性抗体、56.4%为PF4非依赖性抗体;脑静脉窦血栓形成(CVST)几乎仅见于PF4非依赖性抗体患者(22例中11例 vs 17例中1例,P<.05)。

要点

  • 确诊VITT患者中PF4非依赖性抗体占56.4%,PF4依赖性抗体占43.6%。
  • CVST几乎仅发生于PF4非依赖性抗体患者(11/22 vs 1/17,P<.05)。
  • PF4非依赖性抗体结合PF4上肝素结合区和肝素诱导性血小板减少症抗体典型位点两个表位。

核心结论

  • 引起PF4非依赖性血小板活化的VITT抗体代表一个独特患者亚群,可能更易与CVST相关,原因可能是两种不同类型的抗PF4抗体。

研究设计与样本

  • 回顾性队列研究,纳入2021年3月至6月期间检测的确诊VITT患者39例,数据采用匿名表格收集,病例依据血小板活化试验结合高临床怀疑度判定为VITT,并用丙氨酸扫描突变技术进一步表征抗PF4抗体在PF4上的结合区域。

主要发现

  • 确诊VITT患者(n=39)中,17例(43.6%)为PF4依赖性抗体,22例(56.4%)为PF4非依赖性抗体。
  • CVST几乎仅发生于PF4非依赖性抗体患者(22例中11例 vs 17例中1例;P<.05)。
  • PF4非依赖性抗体结合PF4上2个不同表位,即肝素结合区和肝素诱导性血小板减少症抗体典型位点,而PF4依赖性抗体仅结合肝素结合区。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare complication of adenoviral vector-based vaccines against SARS-CoV-2. This syndrome is caused by antibodies against platelet factor 4 (PF4; CXCL4) that lead to platelet activation and is characterized by thrombocytopenia and thrombosis in unusual locations, including cerebral venous sinus thrombosis (CVST). VITT can be classified based on anti-PF4 antibodies properties in vitro: those that require PF4 to activate platelets (PF4-dependent) and those that can activate platelets without additional PF4 (PF4-independent) in the serotonin release assay. OBJECTIVES: We aim to characterize the relationship of VITT platelet-activating profiles with CVST. METHODS: We conducted a retrospective cohort study involving patients with confirmed VITT who were tested between March and June 2021. Data were collected with an anonymized form and cases were identified as VITT with high clinical suspicion according to platelet activation assays. Anti-PF4 antibody binding regions on PF4 were further characterized with alanine scanning mutagenesis. RESULTS: Of the patients with confirmed VITT (n = 39), 17 (43.6%) had PF4-dependent antibodies and 22 (56.4%) had PF4-independent antibodies. CVST occurred almost exclusively in PF4-independent patients (11 of 22 vs 1 of 17; P < .05). Additionally, PF4-independent antibodies bound to 2 distinct epitopes on PF4, the heparin-binding region and a site typical for heparin-induced thrombocytopenia antibodies, whereas PF4-dependent antibodies bound to only the heparin-binding region. CONCLUSION: These findings suggest that VITT antibodies that cause PF4-independent platelet activation represent a unique subset of patients more likely to be associated with CVST, possibly due to the 2 different types of anti-PF4 antibodies.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Huynh A, Arnold DM, Ivetic N, et al. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia. J Thromb Haemost. 2023. PMID: 37394121. doi:10.1016/j.jtha.2023.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。